MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer-Reference-Cited by-同舟云学术

MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer

Published:2014-04 Issue:4 Volume:25 Page:469-483
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Valeri Nicola,Braconi Chiara,Gasparini Pierluigi,Murgia Claudio,Lampis Andrea,Paulus-Hock Viola,Hart Jonathan R.,Ueno Lynn,Grivennikov Sergei I.,Lovat Francesca,Paone Alessio,Cascione Luciano,Sumani Khlea M.,Veronese Angelo,Fabbri Muller,Carasi Stefania,Alder Hansjuerg,Lanza Giovanni,Gafa’ Roberta,Moyer Mary P.,Ridgway Rachel A.,Cordero Julia,Nuovo Gerard J.,Frankel Wendy L.,Rugge Massimo,Fassan Matteo,Groden Joanna,Vogt Peter K.,Karin Michael,Sansom Owen J.,Croce Carlo M.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference51 articles.

1. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis;Aust;Cancer,2002

2. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer;Biswas;Cancer Res.,2004

3. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model;Borinstein;Mol. Carcinog.,2010

4. Comprehensive molecular characterization of human colon and rectal cancer;Nature,2012

5. Personalized colon cancer care in 2010;Catenacci;Semin. Oncol.,2011

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-Targeted Vaccines: A Promising Approach for Viral Attenuation and Immunogenicity Enhancement;Current Gene Therapy;2024-07-31

2. Bcl-2 Up-Regulation Mediates Taxane Resistance Downstream of APC Loss;International Journal of Molecular Sciences;2024-06-19

3. Hypoxia‑regulated exosomal miR‑185 inhibits esophageal squamous cell carcinoma progression and predicts prognosis;Oncology Letters;2024-05-22

4. Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer;International Journal of Colorectal Disease;2024-04-07

5. miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13;Journal of Microbiology;2024-02